Status:
UNKNOWN
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Conquer Cancer Foundation
Conditions:
Stage IV Melanoma
Advanced Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to refine and pilot test educational material developed to educate and support patients receiving immunotherapy for advanced cancer. The intervention is an educational vi...
Detailed Description
This two-part study will 1) refine and 2) pilot test an intervention to improve participant's and caregiver knowledge and increase communication with the oncology team about immunotherapy. * The inte...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All participants (Patients and Caregivers)-Table 1
- Age 18 or older
- Ability to read and respond in English
- Patient Inclusion Criteria (in addition to Table 1)
- Receiving care in the MGH Cancer Center
- Diagnosis of advanced (stage IV) melanoma or advanced, incurable lung cancer, including stage IV non-small cell lung cancer (NSCLC), unresectable stage III NSCLC, extensive-stage small cell lung cancer.
- Plan to initiate immunotherapy with an ICI (pembrolizumab, nivolumab, ipilimumab, atezolizumab or combination), per clinician documentation in the electronic health record or study staff communication with clinician
- Caregiver Inclusion Criteria (in addition to Table 1)
- Identified as "a supportive person involved in their cancer care" by a patient enrolled in the study
- Exclusion criteria
- Major psychiatric condition or comorbid illness that prohibits participation in the study
- Cognitive impairment that prohibits provision of informed consent or participation in the study
- Pregnant women
- Prisoners
Exclusion
Key Trial Info
Start Date :
January 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT04670445
Start Date
January 23 2021
End Date
April 1 2024
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02115